We serve Chemical Name:6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine CAS:65267-47-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine
CAS.NO:65267-47-2
Synonyms:6-Methyl-s-triazolo<4,3-a>pyrimidin
Molecular Formula:C6H6N4
Molecular Weight:134.13900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.398g/cm3
Index of Refraction:1.723
PSA:43.08000
Exact Mass:134.05900
LogP:0.43270
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Methyl-s-triazolo< chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pyrimidin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Methyl-s-triazolo< Use and application,4,3-a> technical grade,usp/ep/jp grade.
Related News: Any drug or medication is composed of two components. 6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine supplier Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. 6-Methyl-[1,2,4]triazolo[4,3-a]pyrimidine factory Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.